Prospect Venture Partners
NinePoint Medical lands $34M for high-res organ imaging
Massachusetts-based NinePoint Medical Imaging closed a $34 million Series B funding round, the company announced today.
NinePoint plans to use the funds to support ongoing U.S. commercial efforts for its NvisionVLE system, which provides high-res, endoscopic imaging of organs and tissues. The system can provide cross-sectional, volumetric views of organs, including tissues below the surface, the company said.